Jon L Giacomin
CIK 1623254 · CEO, Medical Segment · last filed 2026-02-20
Jon L Giacomin is a CEO, Medical Segment who has filed 21 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for ORGO, was dated Feb 20, 2026. Across all open-market trades the lifetime net is −$6.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $14.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$14.31M
2
21
-$6.31M
Holdings By Company
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-20 | ORGO | Grant (A) | +48,828 | $0 | EDGAR |
| 2025-02-21 | ORGO | Grant (A) | +49,575 | $0 | EDGAR |
| 2024-02-23 | ORGO | Grant (A) | +51,020 | $0 | EDGAR |
| 2023-02-24 | ORGO | Grant (A) | +65,737 | $0 | EDGAR |
| 2022-02-17 | ORGO | Grant (A) | +20,547 | $0 | EDGAR |
| 2021-05-11 | ORGO | Grant (A) | +5,319 | $0 | EDGAR |
| 2019-08-19 | CAH | Tax (F) | −6,854 | -$290.7K | EDGAR |
| 2019-02-19 | CAH | Tax (F) | −4,411 | -$244.8K | EDGAR |
| 2018-08-21 | CAH | Sell (S) | −2,890 | -$150.1K | EDGAR |
| 2018-08-16 | CAH | Mixed | +20,494 | -$169.9K | EDGAR |